A novel mutation in the gene for canine acid β-galactosidase that causes GM1-gangliosidosis in Shiba dogs

被引:29
|
作者
Yamato, O [1 ]
Endoh, D
Kobayashi, A
Masuoka, Y
Yonemura, M
Hatakeyama, A
Satoh, H
Tajima, M
Yamasaki, M
Maede, Y
机构
[1] Hokkaido Univ, Lab Internal Med, Dept Vet Clin Sci, Grad Sch Vet Med, Sapporo, Hokkaido, Japan
[2] Rakuno Gakuen Univ, Dept Vet Radiol, Fac Vet Med, Ebetsu, Hokkaido 069, Japan
[3] Midorinomori Anim Hosp, Asahikawa, Hokkaido, Japan
[4] Midorinomori Anim Hosp, Sapporo, Hokkaido, Japan
[5] Hokkaido Univ, Vet Teaching Hosp, Grad Sch Vet Med, Sapporo, Hokkaido, Japan
关键词
D O I
10.1023/A:1021280007739
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A homozygous recessive mutation, causing GM1-gangliosidosis in Shiba dogs, was identified as a deletion of C nucleotide 1668 in the gene for canine acid beta-galactosidase, which was a novel mutation in canine GM1-gangliosidosis.
引用
收藏
页码:525 / 526
页数:2
相关论文
共 50 条
  • [31] Development of an Ex Vivo Gene Therapy for Infantile GM1-Gangliosidosis
    Bucciarelli, Linda
    Milazzo, Rita
    Biffi, Alessandra
    Poletti, Valentina
    MOLECULAR THERAPY, 2022, 30 (04) : 114 - 114
  • [32] BETA-GALACTOSIDASE GENE MUTATION IN A CHILD WITH SEVERE JUVENILE GM1 GANGLIOSIDOSIS
    KAYE, EM
    SHALISH, C
    BREAKEFIELD, XO
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 911 - 911
  • [33] GM1-GANGLIOSIDE ACCUMULATION AND BETA-GALACTOSIDASE DEFICIENCY IN A CASE OF GM1-GANGLIOSIDOSIS (LANDING DISEASE)
    DACREMONT, G
    KINT, JA
    CLINICA CHIMICA ACTA, 1968, 21 (03) : 421 - +
  • [34] Investigational AAV Gene Therapy LYS-GM101 for GM1-Gangliosidosis
    Hocquemiller, Michael
    Olivier, Sophie
    Parker, Samantha
    Aiach, Karen
    Laufer, Ralph
    MOLECULAR THERAPY, 2020, 28 (04) : 562 - 563
  • [35] Development of an ex vivo Gene Therapy for Infantile GM1-Gangliosidosis
    Bucciarelli, L.
    Milazzo, R.
    Poletti, V.
    Biffi, A.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A176 - A177
  • [36] Preclinical Development of an Ex Vivo Gene Therapy for GM1-Gangliosidosis
    Poletti, Valentina
    Biffi, Alessandra
    MOLECULAR THERAPY, 2020, 28 (04) : 488 - 489
  • [37] Comparison of polymerase chain reaction-restriction fragment length polymorphism assay and enzyme assay for diagnosis of GM1-gangliosidosis in Shiba dogs
    Yamato, O
    Kobayashi, A
    Satoh, H
    Endoh, D
    Shoda, T
    Masuoka, Y
    Hatakeyama, A
    Jo, EO
    Asano, T
    Yonemura, M
    Yamasaki, M
    Maede, Y
    JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2004, 16 (04) : 299 - 304
  • [38] GM1-Gangliosidosis in four Romanian patients: clinical picture and mutation report
    Coldea, Cristina
    Serban, Dragos
    Galos, Felicia
    Cinteza, Eliza
    Caciotti, Anna
    Smarandache, Gabriel
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 153 - 154
  • [39] GM1-GANGLIOSIDOSIS - TANDEM DUPLICATION WITHIN EXON-3 OF BETA-GALACTOSIDASE GENE IN AN INFANTILE PATIENT
    OSHIMA, A
    YOSHIDA, K
    ISHIZAKI, A
    SHIMMOTO, M
    FUKUHARA, Y
    SAKURABA, H
    SUZUKI, Y
    CLINICAL GENETICS, 1992, 41 (05) : 235 - 238
  • [40] EXPRESSION STUDIES OF 2 MISSENSE MUTATIONS IN BETA-GALACTOSIDASE THAT RESULT IN GM1-GANGLIOSIDOSIS
    HILSON, WL
    OKAMURAOHO, Y
    ZHANG, S
    CLARKE, JTR
    WHELAN, D
    MAHURAN, D
    CALLAHAN, JW
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 1028 - 1028